SCHEMBL30540230

SCHEMBL30540230

Cc1ncc(-c2ccc(Cl)cc2C=O)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.49
▸ ERN1 O75460 5/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ ROS1 P08922 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ PDE3B Q13370 2/20 0.34
▸ PDE3A Q14432 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ HSD11B1 P28845 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26635196 1.00 XDH (0.49) XDHERN1TDP1ROS1ALDH1A1
SCHEMBL30540241 0.87 XDH (0.51) XDHERN1TDP1ALDH1A1SRC
SCHEMBL26635340 0.87 XDH (0.51) XDHERN1TDP1ALDH1A1SRC
SCHEMBL26635302 0.84 XDH (0.49) XDHERN1TDP1ALDH1A1MAPT
SCHEMBL30540281 0.84 XDH (0.49) XDHERN1TDP1ALDH1A1MAPT
SCHEMBL26635441 0.83 XDH (0.46) XDHERN1TDP1ALDH1A1CYP1A2
SCHEMBL30540272 0.83 XDH (0.46) XDHERN1TDP1ALDH1A1CYP1A2
SCHEMBL26635453 0.82 XDH (0.45) XDHERN1TDP1HPGDMAPT
SCHEMBL30540244 0.80 XDH (0.46) XDHERN1TDP1ALDH1A1MAPT
SCHEMBL26635161 0.80 XDH (0.46) XDHERN1TDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116621778-A USP inhibitor, preparation method and application thereof 北京华森英诺生物科技有限公司 2023-08-22 — — CN disclosed
Send feedback